vitiligo. Vitiligo
Conditions
Interventions
Intervention 1: Intervention group: First intervention: consisting of 19 patients who underwent 20 phototherapy sessions. Intervention 2: Intervention group: Second intervention: consisting of 16 pati
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Definite diagnosis of vitiligo Vitiligo Disease Activity (VIDA) greater than one Not having received any topical or systemic immunosuppressive therapy in the six months prior to study entry Were candidates for phototherapy
Exclusion criteria
Exclusion criteria: Patients with a history of known malignancy, HIV or hepatitis B or C positive Patients with leukopenia or anemia, Patients with renal or hepatic insufficiency, Patients with peptic ulcer disease, Patients using immunosuppressive drugs (prednisone, methotrexate, mycophenolate mofetil, cyclosporine or TNH-alpha inhibitors), Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment effectiveness. Timepoint: Before the study, first month, second month, third month, fourth month. Method of measurement: VASI score and VIDA score.;Patient satisfaction. Timepoint: Before the study, first month, second month, third month, fourth month. Method of measurement: VAS: Visual analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFaegheh Sheikhalizadeh Noubar
Tabriz University of Medical Sciences
Outcome results
None listed